相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris
Youwei Jiang et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions
Shiyi Wang et al.
JOURNAL OF CHROMATOGRAPHY A (2010)
Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
Damian Houde et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
A high-throughput purification of monoclonal antibodies from glycoengineered Pichia pastoris
Youwei Jiang et al.
PROTEIN EXPRESSION AND PURIFICATION (2010)
The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation
Mami Shibata-Koyama et al.
GLYCOBIOLOGY (2009)
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Matthias Peipp et al.
BLOOD (2008)
FcγRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients
Marcia Paiva et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Terminal sugars of Fc glycans influence antibody effector functions of IgGs
T. Shantha Raju
CURRENT OPINION IN IMMUNOLOGY (2008)
Applications of CE SDS gel in development of biopharmaceutical antibody-based products
Richard R. Rustandi et al.
ELECTROPHORESIS (2008)
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
Antonino Musolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies
Roxana M. Ionescu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
Stephen L. Sazinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry
Yusuke Mimura et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Antibodies, Fc receptors and cancer
Falk Nimmerjahn et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Antibody therapeutics: isotype and glycoform selection
Roy Jefferis
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Optimization of humanized IgGs in glycoengineered Pichia pastoris
HJ Li et al.
NATURE BIOTECHNOLOGY (2006)
Glycosylation of recombinant antibody therapeutics
R Jefferis
BIOTECHNOLOGY PROGRESS (2005)
Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro
J Hodoniczky et al.
BIOTECHNOLOGY PROGRESS (2005)
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa
A Okazaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
JJ Uchida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of full-length immunoglobulins in Escherichia coli:: rapid and efficient production of aglycosylated antibodies
LC Simmons et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding
Y Mimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Crystal structure at 2.8 Å of an FcRn/heterodimeric Fc complex:: Mechanism of pH-dependent binding
WL Martin et al.
MOLECULAR CELL (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms
Y Mimura et al.
MOLECULAR IMMUNOLOGY (2000)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
分享论文
